SABR Revolutionizes Prostate Cancer Treatment | Bristol News

A groundbreaking new prostate cancer treatment is hitting the NHS, with the first patient calling it “the NHS at its best.” Derek Chase, a 73-year-old retired doctor, completed just five precise radiotherapy sessions—instead of the usual 20—thanks to Stereotactic Ablative Radiotherapy (SABR). This advanced, image-guided treatment targets cancer cells with pinpoint accuracy, sparing healthy tissue and slashing side effects. Already used for lung and brain cancers, SABR is now expanding to thousands of men with low or intermediate-risk prostate cancer across England. NHS England plans to roll it out to all 48 radiotherapy centers within weeks, potentially helping 17,500 men annually—nearly a third of all prostate cancer diagnoses. Trials are also underway for high-risk cases, promising a faster, more comfortable path to recovery for many. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/90c1b63fb5323abe